Back to 
Citadel Advisors LLC
Citadel Advisors LLC
SMMT
Showing 0 of 3 quarters
Position history for Citadel Advisors LLC's holdings in Summit Therapeutics Inc.
No. Citadel Advisors exited its SMMT (Summit Therapeutics) position in Q2 2019. Its Q1 2019 13F listed 23,783 shares worth $44,000. Citadel Advisors already held SMMT in its Q4 2018 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.